Cellectis
CLLS
80 hedge funds and large institutions have $308M invested in Cellectis in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 18 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
74% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 19
2.53% less ownership
Funds ownership: 38.4% → 35.87% (-2.5%)
11% less funds holding
Funds holding: 90 → 80 (-10)
30% less capital invested
Capital invested by funds: $442M → $308M (-$134M)
38% less call options, than puts
Call options by funds: $984K | Put options by funds: $1.58M
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
+$6.83M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$3.41M |
| 3 |
Legal & General Group
London,
United Kingdom
|
+$3.01M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$2.89M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$38.6M |
| 2 |
Jane Street
New York
|
-$4.67M |
| 3 |
6CM
683 Capital Management
New York
|
-$3.84M |
| 4 |
Goldman Sachs
New York
|
-$1.81M |
| 5 |
Morgan Stanley
New York
|
-$1.2M |
CLLS Hedge Fund Activity: Q1 2021 in Review
80 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2021, worth a combined $308M — down 30% from $442M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CLLS and 11 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 33 added.
The largest buyer was Capital Impact Advisors, adding an estimated $6.83M. The largest seller was ARK Investment Management, cutting an estimated $38.6M.
- 80 institutional investors held Cellectis (CLLS) as of Q1 2021, down from 90 in Q4 2020.
- Funds reported $308M of Cellectis stock for Q1 2021, down 30% quarter-over-quarter.
- 11 funds opened new Cellectis positions in Q1 2021 and 18 closed out, a net change of -7 holders.
- The largest Cellectis buyer in Q1 2021 was Capital Impact Advisors, an estimated $6.83M added.
- The largest Cellectis seller in Q1 2021 was ARK Investment Management, an estimated $38.6M sold.
Based on aggregated 13F filings for Q1 2021.